Clinical trial
Interventional Management of Stroke (IMS) II Study
NCT00243906 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00243906 |
|---|---|
| Title | Interventional Management of Stroke (IMS) II Study |
| Official title | Interventional Management of Stroke (IMS) II Study |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug, Procedure |
| Interventions | Recombinant tissue plasminogen activator, Low-intensity ultrasound |
| Enrollment | 81 |
| Start date | Jan 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Oct 25, 2005 |
| Last update posted | Jul 25, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: